ILK and colorectal carcinoma: Moreover, the same group has identified Integrin Linked Kinase (ILK) as close effector of PrPC, whose expression controls, mesenchymal phenotype of CRC–CSCs subtype, sustaining adhesion, migration, as well as invasion [69].